Fundamental Analysis
43 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +59.2% | +24.4% | 3 / 3 | +171.3% | -17.90 pp | -0.34 pp | +1.5% | 0.92 | 75.90 | 72,3 | +171,3% | 0,3 | +59,2% | 75.90 | 57.23 | +32,6% |
| Pts | 8 | 0 | 12 | 12 | 0 | 4 | 0 | 6 | 4 | |||||||
Valuation annotation:Price: 4.300 (close price on 2026-10-19)EPS (TTM): 56,7
Financial charts
1.Revenue & growth
VND bn72,3Q2/26
1.Revenue & growth
VND bn72,3Q2/26
2.Profit & growth
VND bn0,35Q2/26
3.Profit mix (Penman)
VND bn0,95Q2/26
4.Margins & cost structure
%3.3%Q2/26
5.Returns & cash cycle
% · days-1.6%Q2/26
6.Earnings quality & cash
VND bn28,8Q2/26
7.Asset structure
VND bn727Q2/26
8.Funding & debt health
VND bn · times727Q2/26
9.Revenue backlog
VND bn194Q2/26
10.Valuation
times · %75,9×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %21Q2/26
Adjusted EPS growth, latest quarter
59.2%
Average adjusted EPS growth, 3 quarters
24.4%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26